In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
On World Evidence-Based Healthcare Day (20th October 2021), we explore the role of evidence in an infodemic and how evidence generation processes have been accelerated to offer rapid yet robust...
Read More
Finding, bringing together and synthesising a comprehensive evidence base is a key part of the reimbursement process and the wider market access journey for pharmaceutical products. This evidence generation process...
Read More
Janine Ross, who recently joined the Mtech Access evidence team as a Consultant Information Scientist, explains how her aptitude for searching and identifying evidence data has earned her the nickname...
Read More
Last month, our evidence team tuned in to watch the Virtually Cochrane conference. Each year the Cochrane conference explores the latest thought leadership in systematic review and healthcare evidence. This...
Read More
Shona Lang (Senior Consultant – Systematic Reviews) comments on a recent article in BMJ Evidence-Based Medicine on ‘The need for clinical judgement in the application of evidence-based medicine’1. Having worked...
Read More
Nine of our senior team made the trip to Copenhagen to represent Mtech Access at ISPOR Europe this November. The conference brought together leading experts from across Health Economics and Outcomes...
Read More
In order to comply with the EU regulation on medical devices, the regulatory stage Clinical Evaluation Report (CER) has been the focus of renewed attention by the medical device industry....
Read More
